$ABBV Recent News AbbVie's stock rallies 1.8%, leads

New Post Public Reply Private Reply Replies (0) Message Board

Dec 24, 2014 at 1:21 PM

$ABBV Recent News

AbbVie's stock rallies 1.8%, leads S&P 500 gainers 9:34 a.m. Today - Tomi Kilgore
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
Steelcase shares slide as revenue comes in light 5:42 p.m. Dec. 22, 2014 - MarketWatch
S&P 500, Dow industrials close at records 4:41 p.m. Dec. 22, 2014 - Sara Sjolin
Stock market may wish investors a wary Christmas 8:19 a.m. Dec. 22, 2014 - Shawn Langlois
Express Scripts picks AbbVie over Gilead for hepatitis C drug 7:45 a.m. Dec. 22, 2014 - Joseph Walker
FDA approves AbbVie’s hepatitis treatment 3:33 p.m. Dec. 19, 2014 - Peter Loftus
AbbVie's stock gains 0.8% after FDA approval of hepatitis C treatment 3:21 p.m. Dec. 19, 2014 - Tomi Kilgore
Which stocks the billionaires are buying — and selling 1:32 p.m. Dec. 12, 2014 - The Trading Deck
Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane

Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Today - Zacks.com
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers 9:33 a.m. Today - Seeking Alpha
Gilead Feels The Heat Of Competition 7:59 a.m. Today - Seeking Alpha
Dow Tops 18000 7:50 p.m. Dec. 23, 2014 - The Wall Street Journal Interactive Edition
Express Scripts (ESRX) Picks AbbVie's Hepatitis C Drug - Analyst Blog 4:50 p.m. Dec. 23, 2014 - Zacks.com
AbbVie Puts The Hurt On Gilead Sciences, Closes Exclusive Deal With Express Scripts 4:41 p.m. Dec. 23, 2014 - Seeking Alpha
Dow Reaches Record Close as Santa Claus Rally Hits Day 5 4:04 p.m. Dec. 23, 2014 - TheStreet.com
Investors Should Stay Long Stocks as Market Continues Hitting Highs 3:01 p.m. Dec. 23, 2014 - TheStreet.com
Dow, S&P 500 Near Session Highs After GDP Growth Smashes Expectations 2:25 p.m. Dec. 23, 2014 - TheStreet.com
Gilead Sciences Plunges for Second Day In A Row: What Wall Street's Saying 1:48 p.m. Dec. 23, 2014 - TheStreet.com
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary 12:02 p.m. Dec. 23, 2014 - Zacks.com
Dow Industrials Top 18,000 but Biopharma Stocks Drag Nasdaq Lower 11:29 a.m. Dec. 23, 2014 - TheStreet.com
AbbVie (ABBV): Stock With Unusual Social Activity 11:21 a.m. Dec. 23, 2014 - TheStreet.com
Analysts Predict Big Value Trap for Gilead Investors 11:20 a.m. Dec. 23, 2014 - 247WallSt.com
Dow Crosses 18,000 for First Time on GDP Surge 11:06 a.m. Dec. 23, 2014 - InvestorPlace.com
Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer 11:01 a.m. Dec. 23, 2014 - TheStreet.com
Enanta Is The Big Winner In The Hepatitis C War Between Abbvie And Gilead 8:47 a.m. Dec. 23, 2014 - Seeking Alpha
AbbVie HCV combo med cleared in Canada 7:58 a.m. Dec. 23, 2014 - Seeking Alpha
AbbVie Competes On Price 7:58 a.m. Dec. 23, 2014 - Seeking Alpha
Gilead Sciences: Buy On The Drop? 7:35 a.m. Dec. 23, 2014 - Seeking Alpha

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
AbbVie to Present at Goldman Sachs Healthcare CEOs Unscripted Conference 8:00 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pharma Deals Watch: Coverage Initiated on AstraZeneca, Advaxis, Radius Health, Cubist and AbbVie 9:00 a.m. Dec. 22, 2014 - PR Newswire - PRF
Express Scripts and AbbVie Make Hepatitis C Cure Available to Millions of Patients in Need 7:00 a.m. Dec. 22, 2014 - PR Newswire - PRF
Technical Data on Pharma Stocks - Pfizer, Merck, AbbVie, Akorn, and The Medicines 9:10 a.m. Dec. 12, 2014 - PR Newswire - PRF
AbbVie Presents Results from Phase 2 Study of Investigational Compound Venetoclax (ABT-199/GDC-0199) in Acute Myelogenous Leukemia at the 56th American Society of Hematology Annual Meeting 8:15 p.m. Dec. 7, 2014 - PR Newswire - PRF
Gardy & Notis LLP Issues Notice Of The Filing Of A Securities Class Action Against AbbVie And Its Chief Executive Officer 4:00 p.m. Nov. 26, 2014 - PR Newswire - PRF
CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe 8:00 a.m. Nov. 21, 2014 - PR Newswire - PRF
AbbVie to Present at Jefferies 2014 Global Healthcare Conference 7:00 a.m. Nov. 17, 2014 - PR Newswire - PRF
AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bucket List Wine Dinners Beckon to Los Angeles

Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...

Little Sunshine's Opens New School in Peoria, AZ

Betting On Early Childhood Education Little Sunshine's Playhouse breaks ground on a fresh hub of learning in Peoria, Arizona, and this is no small playdate. It's the dawn of another preschool institution aiming to mold the early years of countless kiddos. The gears turning behind this development are impressive by themselves, but it's what it means for Peoria's families...

TECNO POVA 8 Pro 5G: Blending Speed with Style

TECNO's Newest Launch: A Marriage of Luxurious Design and Performance This ain't just any phone—they've hitched a race car to your pocket. The TECNO POVA 8 Pro 5G Tonino Lamborghini Limited Edition makes a splash, promising to redefine what folks expect from a luxury-tier device, thanks to its endorsed partnership with the iconic Italian brand. But what's all this mean...

Eyepic 2-in-1 Camera Innovates at IFA 2026

Call me a sucker for new tech but what Hohem just unveiled might flip content creation on its head. Welcome the Eyepic—a 2-in-1 pocket gimbal camera stirring things up at IFA 2026 in Berlin. Now, maybe your eyeballs are glazing over with all the camera announcements flooding the market. I get it. Yet, this gadget isn’t just another add-on; it's a sneaky move by Hohem...

Daqo's Power Play: Transforming MEA's Energy Future

Emerging Energy Challenges in the MEA Region Out here in the Middle East and Africa, the energy landscape isn't a lazy river. It's more like white-water rapids, with oil and gas on one bank and the surge of renewables on the other. At the 2026 Middle East Energy showcase, Daqo put everyone on notice with a portfolio that aims to ride those waves—no life vests needed....

Key Considerations for a Landscape Redesign

Starting Your Landscape Redesign the Right Way I’ll give it to you straight: redesigning your yard isn’t just about tossing in some new plants and hoping for the best. Anyone aiming for some backyard nirvana needs to think about the gritty details first—things like drainage, compatibility, and the future growth of those leafy inhabitants. Taking it from Tim Wasmer...

Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Project 777 Bolsters Leadership with AI and Space Experts

Fortifying Project 777 with Tech Titans You'd think bolstering a team THIS stacked would feel daunting to others in the AI race, but A2035 Ventures is just getting started. Their latest move? Bringing in Sean Perry from Meta's Agentic AI and Preston Dunlap, ex-CTO of the U.S. Space Force. These aren't your garden-variety hires; they signify a deliberate step into the next...

USSM and IonicRE Partner to Enhance US Rare Earths Supply

Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...

Choosing a Fiduciary Advisor: Key Family Considerations

Finding the Right Financial Advisor: The Crucial Steps Everyone wants financial security, but picking the right financial advisor is like walking a tightrope. You gotta get it right because it’s your future at stake. In the HelloNation article featuring insights from David Jordan of Jordan Financial Life Planning, families learn the ropes of selecting a fiduciary...